SEC17 Antibody

What is SEC17 and what biological functions does it serve?

SEC17 is a vesicular-fusion protein found in various yeast species that functions as an alpha-SNAP (soluble NSF attachment protein) homolog . In Saccharomyces cerevisiae, it's also known as RNS3, while in Ashbya gossypii it's annotated as AGOS_ABR155C . The protein plays a critical role in the SNARE-mediated membrane fusion pathway, which is essential for intracellular vesicle trafficking and exocytosis. Recent research has demonstrated that SEC17, working together with SEC18, can directly support membrane fusion processes without requiring complete zippering of SNARE complexes . This finding expands our understanding of SEC17's function beyond its traditionally recognized role as a SNARE complex disassembly factor, suggesting it actively participates in the fusion mechanism itself.

What species-specific SEC17 antibodies are available for research applications?

Based on current commercial availability, SEC17 polyclonal antibodies have been developed for at least three yeast species, each with specific reactivity profiles:

All these antibodies are rabbit-derived IgG isotype polyclonal antibodies, purified through antigen-affinity methods, and validated for ELISA and Western blot applications .

How do SEC17 antibodies contribute to our understanding of membrane fusion processes?

SEC17 antibodies serve as essential tools for investigating the molecular mechanisms of SNARE-mediated membrane fusion. Recent research using these antibodies has revealed that SEC17 can modify the conformation of the C-terminus of SNARE complexes, directly influencing fusion events . These findings challenge the conventional model where SNARE zippering alone provides the force for membrane fusion. Experiments using fluorescently labeled SNARE proteins demonstrate that SEC17 promotes C-terminal zippering in a HOPS-dependent manner, indicating a more complex regulatory role than previously understood . By using SEC17 antibodies to inhibit or track the protein's activity, researchers have uncovered that SEC17-induced zippering requires specific apolar heptad-repeat amino acyl residues in the Qa SNARE domain layers +4 to +8, providing molecular detail about the protein's mechanism of action .

What experimental approaches can effectively differentiate between the disassembly and fusion-promoting functions of SEC17?

To distinguish between SEC17's roles in SNARE complex disassembly versus its direct fusion-promoting functions, researchers should employ time-resolved approaches that separate these sequential processes. One effective method involves reconstituted proteoliposome fusion assays where SEC17/SEC18 are added at different stages of the reaction. Recent studies have used Ypt7/RQa proteoliposomes incubated with differentially labeled SNARE proteins to track conformational changes in real-time .

Specifically, researchers can:

• Use fluorescently labeled SNAREs at N-terminal versus C-terminal positions to monitor zippering dynamics

• Compare fusion rates with wild-type versus mutant SEC17 (particularly mutations affecting the apolar binding surface)

• Implement rapid temperature shifts to selectively inhibit ATP-dependent disassembly while allowing fusion promotion

• Apply SEC17 antibodies as temporal inhibitors at different stages of the fusion reaction

Results should be analyzed using FRET measurements, which can reveal subtle changes in SNARE complex conformation upon SEC17 binding. Control experiments should include reactions with buffer instead of SEC17 and comparisons with truncated SNARE domains (such as Qa3Δ) that prevent normal interactions .

How do mutations in SEC17 affect its interaction with SNARE complexes and subsequent membrane fusion activity?

Mutations in SEC17, particularly those affecting its apolar binding surface, significantly alter its capacity to interact with and modify SNARE complexes. FRET-based experiments have demonstrated that SEC17's ability to promote C-terminal zippering depends critically on specific structural elements. When the apolar heptad-repeat amino acyl residues in Qa SNARE domain layers +4 to +8 were mutated to glycine, SEC17-induced zippering was substantially reduced .

The functional consequences of SEC17 mutations include:

• Altered binding affinity to partially assembled SNARE complexes

• Reduced capacity to promote conformational changes in SNARE C-termini

• Diminished membrane fusion rates in reconstituted systems

• Changes in cooperativity with other fusion factors like HOPS

These findings suggest that SEC17's fusion-promoting activity requires precise molecular interactions with SNARE complexes, beyond its recognized role in recruiting SEC18 for disassembly. Researchers investigating SEC17 mutations should incorporate both structural and functional assays to comprehensively characterize phenotypes, using SEC17 antibodies to quantify binding properties and localization patterns .

What is the relationship between SEC17 and mammalian α-SNAP, and how can antibody cross-reactivity be utilized or avoided in comparative studies?

SEC17 and mammalian α-SNAP (Alpha-soluble NSF attachment protein) are functional homologs that share significant structural and mechanistic similarities. In Saccharomyces cerevisiae, SEC17 is explicitly annotated as "Alpha-soluble NSF attachment protein" and "SNAP-alpha" . Despite their evolutionary relationship, these proteins exhibit species-specific sequence variations that affect antibody recognition.

For comparative studies across species, researchers should consider:

• Epitope mapping: Determine which regions of SEC17/α-SNAP are conserved versus divergent to predict cross-reactivity

• Pre-absorption controls: Test antibody specificity by pre-incubation with recombinant proteins from different species

• Sequential immunoprecipitation: Use species-specific antibodies in tandem to separate mixed protein populations

• Recombinant protein standards: Include purified proteins from each species as positive controls in immunoblots

When cross-reactivity is desired (e.g., for evolutionary studies), researchers should target highly conserved epitopes. Conversely, to achieve species specificity, antibodies should be raised against divergent regions, particularly the N- and C-termini which typically show greater sequence variation than functional domains. Western blot validation with samples from multiple species is essential before using these antibodies in more complex applications .

What are the optimal conditions for using SEC17 antibodies in immunofluorescence microscopy studies?

For optimal immunofluorescence results with SEC17 antibodies, researchers should implement a specialized protocol accounting for SEC17's membrane association and dynamic localization. Based on the available data and established practices for vesicular trafficking proteins, the following parameters are recommended:

• Fixation method: Use 4% paraformaldehyde for 15-20 minutes at room temperature, as harsh fixatives may disrupt epitope accessibility. For dual fixation, follow with brief (5 minute) exposure to pre-chilled methanol at -20°C to improve membrane permeabilization.

• Blocking solution: Use 5% normal serum (matched to secondary antibody host) with 0.1% saponin in PBS to maintain membrane structure while allowing antibody access.

• Antibody dilution: Start with 1:100-1:200 dilutions for rabbit anti-SEC17 polyclonal antibodies, optimizing based on signal-to-noise ratio .

• Incubation conditions: Primary antibody incubation should be conducted overnight at 4°C to maximize specific binding while minimizing background.

• Essential controls:

  • Omission of primary antibody to assess secondary antibody background

  • Pre-absorption with recombinant SEC17 protein to confirm specificity

  • Co-staining with markers for relevant compartments (e.g., Golgi, ER, endosomes)

  • siRNA/shRNA knockdown samples as negative controls

• Signal amplification: Consider using tyramide signal amplification for low-abundance detection, particularly when examining physiological (non-overexpressed) levels of SEC17.

These parameters should be further optimized for each specific cell type and experimental question.

What troubleshooting approaches can address common challenges when using SEC17 antibodies in Western blot applications?

When encountering difficulties with SEC17 antibodies in Western blot applications, researchers should systematically address common issues using the following troubleshooting approach:

• High background:

  • Increase blocking stringency (5% non-fat milk + 1% BSA in TBST)

  • Reduce primary antibody concentration (try 1:1000-1:5000)

  • Include 0.1% SDS in antibody dilution buffer to reduce non-specific interactions

  • Extend washing steps (5 x 10 minutes in TBST with gentle agitation)

• Weak or absent signal:

  • Optimize protein extraction methods for membrane-associated proteins (consider using 1% Triton X-100 or NP-40)

  • Adjust SDS-PAGE conditions to prevent potential epitope masking (reduce SDS concentration to 0.1%)

  • Try heat-based versus chemical-based antigen retrieval on the membrane after transfer

  • Increase protein loading (50-100 μg total protein per lane)

  • Reduce methanol concentration in transfer buffer to 10% to improve high-molecular-weight protein transfer

• Multiple bands/non-specific bands:

  • Increase antibody specificity through longer incubation at 4°C (overnight) at higher dilution

  • Compare patterns between different species to identify conserved specific bands

  • Run parallel blots with competing peptide blocks to identify specific signals

  • Use gradient gels (4-20%) to improve resolution of similar molecular weight proteins

  • Consider native-PAGE if conformation-dependent epitopes are suspected

• Sample preparation considerations:

  • Include protease inhibitors (complete cocktail) to prevent degradation

  • Add N-ethylmaleimide (20 mM) to preserve SNARE complex interactions if studying assembled complexes

  • Avoid boiling samples when detecting SNARE complexes, as high temperatures can dissociate these structures

These approaches can be systematically applied while maintaining appropriate positive controls using recombinant SEC17 protein .

How can researchers design definitive experiments to characterize SEC17's role in SNARE-mediated fusion using available antibodies?

To definitively characterize SEC17's role in SNARE-mediated fusion, researchers should design multi-faceted experiments that systematically dissect its contributions. Based on recent findings, the following experimental strategy is recommended:

• In vitro reconstitution experiments:

  • Prepare proteoliposomes bearing Ypt7/R-SNARE and either wild-type Qa or Qa with mutations in layers +4 to +8

  • Use C-terminally labeled *Qb and *Qc SNAREs to monitor zippering via FRET

  • Measure lipid mixing (with lipid FRET pairs) and content mixing (with soluble FRET pairs) in parallel

  • Compare fusion rates with addition of purified SEC17, SEC17 antibodies, or buffer controls

  • Include reactions with truncated Qa (Qa3Δ) to assess zippering requirements

• Antibody inhibition assays:

  • Apply SEC17 antibodies at different stages of fusion reactions to determine timing of SEC17 action

  • Use Fab fragments to eliminate potential steric complications of full IgG molecules

  • Perform dose-response experiments with antibodies to determine inhibitory concentrations

  • Include isotype-matched control antibodies to rule out non-specific effects

• Genetic complementation studies:

  • Generate SEC17 temperature-sensitive yeast strains

  • Introduce wild-type or mutant SEC17 variants and assess rescue of fusion phenotypes

  • Use SEC17 antibodies to confirm expression levels across complemented lines

  • Measure secretion efficiency as functional readout of fusion activity

• Live-cell imaging approaches:

  • Develop split-fluorescent protein systems to visualize SEC17-SNARE interactions in real-time

  • Use SEC17 antibodies in proximity ligation assays to map interaction networks

  • Implement super-resolution microscopy to define spatial organization during fusion events

  • Correlate SEC17 localization with membrane remodeling events

These comprehensive approaches, when combined, can distinguish between SEC17's roles in SNARE complex assembly, membrane deformation, fusion pore formation, and complex disassembly .

What considerations should guide the selection between polyclonal and monoclonal SEC17 antibodies for specific research applications?

The choice between polyclonal and monoclonal SEC17 antibodies should be guided by the specific research question, experimental design, and technical requirements. Currently, the commercially available SEC17 antibodies appear to be polyclonal rabbit antibodies , but researchers may consider developing or sourcing monoclonal alternatives for certain applications.

Selection considerations include:

• Experimental application:

  • For detection of native SEC17 in complex samples: Polyclonal antibodies offer higher sensitivity through multi-epitope recognition

  • For distinguishing between highly similar proteins (e.g., SEC17 vs. α-SNAP): Monoclonal antibodies provide greater specificity

  • For co-immunoprecipitation of SNARE complexes: Carefully selected monoclonal antibodies that don't disrupt complex formation

  • For super-resolution imaging: Monoclonal antibodies to ensure consistent epitope targeting

• Technical requirements:

  • Reproducibility across experiments: Monoclonal antibodies eliminate lot-to-lot variation

  • Long-term studies: Monoclonal hybridomas provide renewable antibody source

  • Multiplexed detection: Monoclonal antibodies from different species enable simultaneous staining

  • Quantitative analyses: Monoclonal antibodies with known binding stoichiometry for calibrated measurements

• Experimental design considerations:

  • If studying conformational changes in SEC17 during SNARE interactions: Polyclonal antibodies may recognize multiple conformational states

  • If targeting specific functional domains (e.g., SNARE-binding region): Monoclonal antibodies with mapped epitopes

  • If working across species: Polyclonal antibodies against conserved regions may provide wider cross-reactivity

• Sample type influences:

  • Fixed versus live cell imaging: Consider membrane permeability and epitope accessibility

  • Denatured versus native protein detection: Match antibody validation conditions to experimental conditions

  • High versus low abundance targets: Consider signal amplification requirements

While polyclonal SEC17 antibodies like those listed in the catalog offer advantages for initial characterization and detection in various applications, researchers pursuing mechanistic studies of SEC17 function in SNARE-mediated fusion may benefit from developing targeted monoclonal antibodies against specific functional domains.